세계의 심장 초음파 시장 : 시장 규모, 점유율, 동향-제품별, 용도별, 최종 사용자별, 지역별 - 예측(-2029년)

The global intracardiac echocardiography (ICE) market is projected to reach USD 545 million by 2029 from USD 333 million in 2024, growing at a CAGR of 10.3% during the forecast period. The projected market growth for intracardiac echocardiography (ICE) is supported by the convergence of benefits. The projected expansion of the intracardiac echocardiography (ICE) market is driven by demographic trends favoring an aging population, continuous advancements in diagnostic technologies, increased adoption of advanced imaging tools, and the capability to deliver real-time, high-resolution imaging of cardiac structures and blood flow. These factors synergistically contribute to the growth prospects of the ICE market in the forecasted period.

" ICE Ultrasound Systems with Inbuild Software Applications segment to register largest market share in 2023-2029."

Based on the product, the intracardiac echocardiography (ICE) market is segmented into ICE Ultrasound Systems with Inbuild Software Applications (2D ultrasound systems, 3D/4D ultrasound systems, doppler ultrasound systems), ICE Catheters (Dopper ICE catheters, phased - array ICE catheters, fixed - array ICE catheters, mechanical rotational ICE catheters) , ICE Consoles (cart/ trolley-based consoles, hand-held/ portable consoles), guiding catheters and sheaths, disposable accessories, and softwares are used in intracardiac echocardiography (ICE) taken into account while estimating the entire market. The ICE Ultrasound Systems segment registered the largest market share for the forecasted year of 2024-2029. Developments in ultrasound transducer technology and catheter designs, as well as its integration with other imaging tools to give comprehensive visualisation and navigation, are responsible for the emergence of intracardiac echocardiography ultrasound systems. Consumer demand for minimally invasive procedures, improved software applications, and an increase in the rate of coronary diseases are all contributing to the expansion and widespread use of ICE ultrasound devices.

"Electrophysiolgy segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by application."

Based on the application, the intracardiac echocardiography (ICE) market is segmented into electrophysiology, structural heart defects (mitral valve repair/ replacement, aortic valve replacement and other heart defects), cardiac monitoring, left atrial appendage closure, and other applications. In 2023, the electrophysiolgy segment accounted the largest share of global intracardiac echocardiography (ICE) market. Real-time visualization capabilities, improved safety and accuracy in procedures, and the ability to monitor cardiac health over extended periods for early disease detection are pivotal drivers propelling growth in the electrophysiology in intracardia echocardiography market.

"hospitals & surgical centers: diagnostic segment held the largest share of intracardiac echocardiography (ICE) market in 2023, by End-user."

Based on the end-user, the intracardiac echocardiography (ICE) market is segmented into Hospital-based cathlabs/ hybrid or interventional, hospitals & surgical centers: diagnostic, Ambulatory surgical centers (ASCs) and independent diagnostic centers and Other end users. In 2023, the hospitals & surgical centers: diagnostic segment had the largest share of the global intracardiac echocardiography (ICE) market. The growth within hospital and surgical centers:diagnostic segment is propelled by continuous advancements in diagnostic technology, escalating consumer demand for superior diagnostic services, and facilitated expansion of diagnostic capabilities due to favorable regulatory environments and increased adoption of modern diagnostic tools.

"Asia Pacific to register significant growth rate in the market during the forecast period."

For the forecasting period 2024-2029, The Asia-Pacific (APAC) region is anticipated to experience substantial growth throughout the forecast period. Asia Pacific comprises Japan, India, China, South Korea, Australia, and RoAPAC. The Asia-Pacific (APAC) region has experienced a notable acceleration in the market growth rate for intracardiac echocardiography (ICE). Several factors have contributed to the growth of the intracardiac echocardiography (ICE) market in the APAC region. Continuous innovations in ultrasound technology are driving this expansion. Additionally, governments in the Asia Pacific are making significant investments in healthcare infrastructure and advanced medical technologies. The rising incidence of cardiovascular diseases in the region further increases the demand for advanced diagnostic and imaging technologies like ICE, aiming to enhance patient care and outcomes.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
• By Designation: C-level-- 27%, Director-level-18%, and Others-55%
• By Region: North America-50%, Europe-20%, Asia Pacific-15%, Latin America-10%, and the Middle East & Africa-5%

Prominent players in this market are Johnson & Johson Medtech (US), Medtronic (Ireland), Abbott Laboratories (US), Siemens Healthineers (Germany), Philips healthcare (Netherland) among others.

Research Coverage

• The report studies the intracardiac echocardiography (ICE) market based on products, application, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global intracardiac echocardiography (ICE) market.
• The report forecasts the revenue of market segments with respect to five major regions.

Key Benefits of Buying the Report:

The report will help the new entrants/ market leaders/smaller firms in this market with investment evaluation viability within the intracardiac echocardiography (ICE) market through a thorough analysis of comprehensive data, thereby facilitating robust risk assessment and enabling well-informed investment determinations. Benefit from meticulous market segmentation encompassing end-user, and regional dimensions, affording tailored insights for precise segment targeting. The report also provides an all-encompassing evaluation of encapsulating pivotal trends, challenges, growth catalysts and prospects, thereby empowering strategic decision-making with astute discernment.

The report provides insights on the following pointers:

• Analysis of key drivers (increasing cardiac issues in overall population, collaboration of other imaging techniques and AI with intracardiac echocardiography technology), restraints (The availability of trained personnel is inconsistent. Additionally, ICE procedures involve significant risks of complications), opportunities (scope of clinical applications for intracardiac echocardiography (ICE) in structural heart disease interventions is expanding), and challenges (incur cost barrier) influencing the growth of the intracardiac echocardiography (ICE) market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the intracardiac echocardiography (ICE) market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the intracardiac echocardiography (ICE) market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the intracardiac echocardiography (ICE) market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Siemens Healthineers (Germany), among others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 INCLUSIONS & EXCLUSIONS
• 1.4 MARKET SCOPE
  • 1.4.1 MARKETS COVERED
• 1.5 YEARS CONSIDERED
• 1.6 CURRENCY CONSIDERED
• 1.7 MARKET STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
• 2.2 RESEARCH DESIGN
  • 2.2.1 SECONDARY RESEARCH
    • 2.2.1.1 Key data from secondary sources
  • 2.2.2 PRIMARY RESEARCH
    • 2.2.2.1 Primary sources
    • 2.2.2.2 Key industry insights
    • 2.2.2.3 Breakdown of primaries
• 2.3 MARKET SIZE ESTIMATION
  • 2.3.1 BOTTOM-UP APPROACH
    • 2.3.1.1 Approach 1: Company revenue estimation approach
    • 2.3.1.2 Approach 2: Customer-based market estimation
    • 2.3.1.3 Approach 3: Top-down approach
    • 2.3.1.4 Approach 4: Primary interviews
• 2.4 DATA TRIANGULATION & MARKET BREAKDOWN
• 2.5 MARKET SHARE ASSESSMENT
• 2.6 STUDY ASSUMPTIONS
• 2.7 ASSUMPTIONS
• 2.8 RISK ASSESSMENT
• 2.9 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET OVERVIEW
• 4.2 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION, 2024 VS. 2029 (USD MILLION)
• 4.3 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION AND END USER, 2023 (USD MILLION)
• 4.4 GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Emergence of predictive analytics in ICE technology
    • 5.2.1.2 Expanding clinical use cases of ICE technology
    • 5.2.1.3 Ongoing integration of ICE technology with other imaging modalities
    • 5.2.1.4 Rising prevalence of cardiac disorders
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Premium product pricing
    • 5.2.2.2 Dearth of healthcare professionals
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Broadening clinical applications of ICE in structural heart disease interventions
    • 5.2.3.2 Advances in 3D and real-time 3D (4D) imaging
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Technical limitations
    • 5.2.4.2 Increased pricing pressure on market players
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 THREAT OF NEW ENTRANTS
  • 5.3.2 THREAT OF SUBSTITUTES
  • 5.3.3 BARGAINING POWER OF SUPPLIERS
  • 5.3.4 BARGAINING POWER OF BUYERS
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 REGULATORY ANALYSIS
  • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4.2 KEY REGULATORY GUIDELINES
    • 5.4.2.1 North America
      • 5.4.2.1.1 US
      • 5.4.2.1.2 Canada
    • 5.4.2.2 Europe
    • 5.4.2.3 Asia Pacific
      • 5.4.2.3.1 Japan
      • 5.4.2.3.2 India
      • 5.4.2.3.3 China
• 5.5 REIMBURSEMENT SCENARIO
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 INVESTMENT & FUNDING SCENARIO
• 5.8 TECHNOLOGY ANALYSIS
  • 5.8.1 KEY TECHNOLOGIES
    • 5.8.1.1 Phased-array ICE
    • 5.8.1.2 Rotational ICE
    • 5.8.1.3 Doppler imaging
    • 5.8.1.4 3D ICE technology
  • 5.8.2 COMPLEMENTARY TECHNOLOGIES
    • 5.8.2.1 Intravascular ultrasound (IVUS)
    • 5.8.2.2 Value-added software (AI and IoT)
    • 5.8.2.3 Clinical decision support systems
    • 5.8.2.4 Electrophysiology (EP) mapping systems
  • 5.8.3 ADJACENT TECHNOLOGIES
    • 5.8.3.1 Event monitors
    • 5.8.3.2 Holter monitors
• 5.9 VALUE CHAIN ANALYSIS
  • 5.9.1 RESEARCH & DEVELOPMENT
  • 5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT
  • 5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
• 5.10 SUPPLY CHAIN ANALYSIS
  • 5.10.1 PROMINENT COMPANIES
  • 5.10.2 SMALL & MEDIUM-SIZED ENTERPRISES
  • 5.10.3 END USERS
• 5.11 PRICING ANALYSIS
• 5.12 PATENT ANALYSIS
• 5.13 TRADE ANALYSIS
• 5.14 KEY CONFERENCES & EVENTS, 2024-2025
• 5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.16 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.16.2 BUYING CRITERIA
• 5.17 ADJACENT MARKET ANALYSIS
• 5.18 UNMET NEEDS & KEY PAIN POINTS
• 5.19 ARTIFICIAL INTELLIGENCE IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE)

6 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 ICE ULTRASOUND SYSTEMS WITH INBUILT SOFTWARE
  • 6.2.1 2D ULTRASOUND SYSTEMS
    • 6.2.1.1 Increasing integration of modern ICE systems with other diagnostic systems to drive market growth
  • 6.2.2 3D/4D ULTRASOUND SYSTEMS
    • 6.2.2.1 Increasing incidence of cardiovascular diseases worldwide to drive growth
  • 6.2.3 DOPPLER ULTRASOUND SYSTEMS
    • 6.2.3.1 Higher resolution imaging and advanced Doppler techniques to enhance capability of ICE systems
• 6.3 ICE CATHETERS
  • 6.3.1 DOPPLER ICE CATHETERS
    • 6.3.1.1 Growing preference for minimally invasive cardiac procedures to support market growth
  • 6.3.2 PHASED-ARRAY ICE CATHETERS
    • 6.3.2.1 High cost and limited applications to restrict market growth
  • 6.3.3 FIXED-ARRAY ICE CATHETERS
    • 6.3.3.1 High demand for advanced cardiac imaging solutions to drive innovation and adoption of fixed-array catheters
  • 6.3.4 MECHANICAL ROTATIONAL ICE CATHETERS
    • 6.3.4.1 Innovations in catheter technology to boost market growth
• 6.4 ICE CONSOLES
  • 6.4.1 CART/TROLLEY-BASED CONSOLES
    • 6.4.1.1 Rising geriatric population to fuel market growth
  • 6.4.2 HANDHELD/PORTABLE CONSOLES
    • 6.4.2.1 Increasing adoption of portable consoles in healthcare facilities to drive market growth
• 6.5 GUIDING CATHETERS & SHEATHS
  • 6.5.1 INCREASING INTEGRATION OF GUIDING CATHETERS & SHEATHS WITH PORTABLE ICE CONSOLES TO PROPEL MARKET GROWTH
• 6.6 DISPOSABLE ACCESSORIES
  • 6.6.1 COST OF DISPOSABLE ACCESSORIES TO PLAY SIGNIFICANT ROLE IN DRIVING MARKET GROWTH
• 6.7 SOFTWARE
  • 6.7.1 INCREASING ADOPTION OF PREDICTIVE ANALYTICS FOR REAL-TIME IMAGING TO BOOST MARKET

7 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 STRUCTURAL HEART DEFECTS
  • 7.2.1 MITRAL VALVE REPAIR/REPLACEMENT
    • 7.2.1.1 Growing burden of cardiovascular diseases to drive market
  • 7.2.2 AORTIC VALVE REPLACEMENT
    • 7.2.2.1 Growing demand for effective imaging tools like ICE to boost market
  • 7.2.3 OTHER STRUCTURAL HEART DEFECTS
• 7.3 ELECTROPHYSIOLOGY
  • 7.3.1 GROWING INTEGRATION OF ICE WITH MAPPING SYSTEMS TO DRIVE MARKET GROWTH
• 7.4 LEFT ATRIAL APPENDAGE CLOSURE
  • 7.4.1 BENEFITS SUCH AS MINIMIZATION OF RADIATION EXPOSURE IN PROCEDURES LIKE LAA CLOSURE TO SUPPORT GROWTH
• 7.5 CARDIAC MONITORING
  • 7.5.1 BETTER CLINICAL DECISION-MAKING AND IMPROVED PATIENT OUTCOMES TO SUPPORT SEGMENT GROWTH
• 7.6 OTHER APPLICATIONS

8 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS & SURGICAL CENTERS
  • 8.2.1 ABILITY TO AFFORD HIGH INSTALLATION & MAINTENANCE COSTS OF ICE TECHNOLOGIES TO BOOST MARKET
• 8.3 AMBULATORY SURGICAL CENTERS
  • 8.3.1 COST-EFFECTIVENESS AND CONVENIENCE OF AMBULATORY SURGICAL CENTERS TO DRIVE GROWTH
• 8.4 HOSPITAL-BASED CATH LABS/HYBRID OR INTERVENTIONAL CENTERS
  • 8.4.1 GROWING USE OF ICE IN CATH LABS FOR MINIMALLY INVASIVE CARDIAC PROCEDURES TO BOOST MARKET
• 8.5 INDEPENDENT DIAGNOSTIC CENTERS
  • 8.5.1 SPECIALIZED EXPERTISE AND ADVANCED ICE TECHNOLOGY IN INDEPENDENT DIAGNOSTIC CENTERS TO BOOST GROWTH
• 8.6 OTHER END USERS

9 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 US
    • 9.2.1.1 Growing number of FDA approvals for ICE devices to support market growth
  • 9.2.2 CANADA
    • 9.2.2.1 Growing public-private funding for research to drive market growth
• 9.3 EUROPE
  • 9.3.1 GERMANY
    • 9.3.1.1 Rising healthcare expenditure and manufacturer expansion to boost market growth
  • 9.3.2 UK
    • 9.3.2.1 Increasing public & private investments to contribute to market growth
  • 9.3.3 FRANCE
    • 9.3.3.1 Statutory health insurance system to support market growth
  • 9.3.4 ITALY
    • 9.3.4.1 Rising incidence of cardiac diseases to drive adoption of ICE devices
  • 9.3.5 SPAIN
    • 9.3.5.1 Growing number of surgical procedures to drive market growth in Spain
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 JAPAN
    • 9.4.1.1 Large geriatric population and favorable reimbursement scenario to support market growth
  • 9.4.2 CHINA
    • 9.4.2.1 Growing focus of local and international market players to favor market growth
  • 9.4.3 INDIA
    • 9.4.3.1 Increasing government-implemented healthcare initiatives to support market growth
  • 9.4.4 AUSTRALIA
    • 9.4.4.1 R&D tax incentive program to support market growth
  • 9.4.5 SOUTH KOREA
    • 9.4.5.1 Supportive government initiatives to drive market growth
  • 9.4.6 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 BRAZIL
    • 9.5.1.1 Brazil to dominate LATAM market
  • 9.5.2 MEXICO
    • 9.5.2.1 Favorable investment scenario for medical device manufacturers to drive market growth
  • 9.5.3 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 GCC COUNTRIES
    • 9.6.1.1 Developments in healthcare infrastructure and high government expenditure to drive market
  • 9.6.2 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGY/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET
• 10.3 REVENUE ANALYSIS
• 10.4 MARKET SHARE ANALYSIS
  • 10.4.1 INTRACARDIAC ECHOCARDIOGRAPHY (ICE) MARKET SHARE, BY KEY PLAYER, 2023
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 10.5.5.1 Company footprint
    • 10.5.5.2 Product footprint
    • 10.5.5.3 Application footprint
    • 10.5.5.4 End-user footprint
    • 10.5.5.5 Region footprint
• 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 RESPONSIVE COMPANIES
  • 10.6.3 DYNAMIC COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPANY BENCHMARKING: STARTUPS/SMES, 2023
• 10.7 COMPANY VALUATION AND FINANCIAL METRICS
• 10.8 PRODUCT/BRAND COMPARISON
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 10.9.2 DEALS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 MEDTRONIC
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product approvals
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Key strengths
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 ABBOTT
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Product launches and approvals
      • 11.1.2.3.2 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Key strengths
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 SIEMENS HEALTHINEERS AG
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches and approvals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Key strengths
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 GE HEALTHCARE
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Product approvals
      • 11.1.4.3.2 Deals
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Key strengths
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses and competitive threats
  • 11.1.5 BOSTON SCIENTIFIC CORPORATION
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Product launches
      • 11.1.5.3.2 Deals
      • 11.1.5.3.3 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Key strengths
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 PHILIPS HEALTHCARE
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches and approvals
      • 11.1.6.3.2 Deals
      • 11.1.6.3.3 Expansions
    • 11.1.6.4 MnM view
      • 11.1.6.4.1 Key strengths
      • 11.1.6.4.2 Strategic choices
      • 11.1.6.4.3 Weaknesses and competitive threats
  • 11.1.7 JOHNSON & JOHNSON MEDTECH
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Product launches and approvals
      • 11.1.7.3.2 Deals
    • 11.1.7.4 MnM view
      • 11.1.7.4.1 Key strengths
      • 11.1.7.4.2 Strategic choices
      • 11.1.7.4.3 Weaknesses and competitive threats
  • 11.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches
      • 11.1.8.3.2 Deals
  • 11.1.9 EDWARDS LIFESCIENCES CORPORATION
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 CANON MEDICAL SYSTEMS CORPORATION
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Product launches
      • 11.1.10.3.2 Deals
  • 11.1.11 FUJIFILM HOLDINGS CORPORATION
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Product launches
      • 11.1.11.3.2 Deals
  • 11.1.12 GUERBET
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
  • 11.1.13 TERUMO CORPORATION
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Deals
  • 11.1.14 LIVANOVA
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
  • 11.1.15 INFRAREDX INC.
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
  • 11.1.16 STEREOTAXIS, INC.
    • 11.1.16.1 Business overview
    • 11.1.16.2 Products offered
    • 11.1.16.3 Recent developments
      • 11.1.16.3.1 Deals
  • 11.1.17 B. BRAUN SE
    • 11.1.17.1 Business overview
    • 11.1.17.2 Products offered
  • 11.1.18 ESAOTE SPA
    • 11.1.18.1 Business overview
    • 11.1.18.2 Products offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Product launches
• 11.2 OTHER PLAYERS
  • 11.2.1 CHISON MEDICAL TECHNOLOGIES CO., LTD.
  • 11.2.2 SHIFAMED, LLC
  • 11.2.3 CONAVI MEDICAL INC.
  • 11.2.4 XUZHOU KAIXIN ELECTRONIC INSTRUMENT CO., LTD.
  • 11.2.5 BK MEDICAL
  • 11.2.6 BENQ MEDICAL TECHNOLOGY
  • 11.2.7 ECHONOUS INC.
  • 11.2.8 VOLTA MEDICAL
  • 11.2.9 TRIVITRON HEALTHCARE
  • 11.2.10 ECHOPIXEL
  • 11.2.11 CATHVISION
  • 11.2.12 PIE MEDICAL IMAGING BV

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS